Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin and NAC in Bipolar Alcoholics
NCT03220776Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Aug 2017
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin, acetylcysteine in alcohol use disorder (AUD), bipolar disorder (BD), sponsored by Medical University of South Carolina. Started Aug 2017; status: completed.
02
Drugs
gabapentinacetylcysteine
03
Conditions
alcohol use disorder (AUD)bipolar disorder (BD)
Beyond the preview
Go deeper on NCT03220776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03220776.